CSF2 and cancer: Taken together, these data indicated that the engineered CCL21a/ExoGM‐CSF+Ce6@nanoGel together with ultrasound irradiation possessed the ability to elicit efficient antigen‐specific antitumor immunity in solid tumor models, demonstrating great potential for future clinical cancer vaccine development.